72 related articles for article (PubMed ID: 25383370)
21. The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study.
Seve P; Sawyer M; Hanson J; Broussolle C; Dumontet C; Mackey JR
Cancer; 2006 May; 106(9):2058-66. PubMed ID: 16583433
[TBL] [Abstract][Full Text] [Related]
22. [Clinical efficacy and prognostic factors for cryoablation patients with advanced hepatocellular carcinoma].
Chang XJ; Lu YY; Bai WL; Chen Y; An LJ; Zhou L; Wang H; Wu Y; Liu Z; Lou M; Zeng Z; Su SH; Yang YP
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):759-63. PubMed ID: 22409849
[TBL] [Abstract][Full Text] [Related]
23. Two decades of experience with hepatic cryotherapy for advanced colorectal metastases.
Ng KM; Chua TC; Saxena A; Zhao J; Chu F; Morris DL
Ann Surg Oncol; 2012 Apr; 19(4):1276-83. PubMed ID: 21913018
[TBL] [Abstract][Full Text] [Related]
24. The insertion of self expanding metal stents with flexible bronchoscopy under sedation for malignant tracheobronchial stenosis: a single-center retrospective analysis.
McGrath EE; Warriner D; Anderson P
Arch Bronconeumol; 2012 Feb; 48(2):43-8. PubMed ID: 22137422
[TBL] [Abstract][Full Text] [Related]
25. Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study.
Belani CP; Brodowicz T; Ciuleanu TE; Krzakowski M; Yang SH; Franke F; Cucevic B; Madhavan J; Santoro A; Ramlau R; Liepa AM; Visseren-Grul C; Peterson P; John WJ; Zielinski CC
Lancet Oncol; 2012 Mar; 13(3):292-9. PubMed ID: 22336221
[TBL] [Abstract][Full Text] [Related]
26. Role of emphysema and airway obstruction in prognosis of lung cancer.
Gullón JA; Suárez I; Medina A; Rubinos G; Fernández R; González I
Lung Cancer; 2011 Feb; 71(2):182-5. PubMed ID: 20554345
[TBL] [Abstract][Full Text] [Related]
27. Does chemosensitivity-assay-directed therapy have an influence on the prognosis of patients with malignant melanoma stage IV? A retrospective study of 14 patients with malignant melanoma stage IV.
Doerler M; Hyun J; Venten I; Potthoff A; Bartke U; Serova K; Hoextermann S; Altmeyer P; Brockmeyer NH
Eur J Med Res; 2007 Oct; 12(10):497-502. PubMed ID: 18024256
[TBL] [Abstract][Full Text] [Related]
28. Performance status and sensitivity to first-line chemotherapy are significant prognostic factors in patients with recurrent small cell lung cancer receiving second-line chemotherapy.
Kim YH; Goto K; Yoh K; Niho S; Ohmatsu H; Kubota K; Saijo N; Nishiwaki Y
Cancer; 2008 Nov; 113(9):2518-23. PubMed ID: 18780323
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes after first-line EGFR inhibitor treatment for patients with NSCLC, EGFR mutation, and poor performance status.
Okuma Y; Hosomi Y; Nagamata M; Yamada Y; Sekihara K; Kato K; Hishima T; Okamura T
Anticancer Res; 2013 Nov; 33(11):5057-64. PubMed ID: 24222150
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic factor analysis of 77 old patients with acute myelogenous leukemia].
Shao B; Gao YR; Wang C; Yan SK; Cai Q; Jiang JL; Yang J; Bai HT; Zhao M; Zhao CX
Ai Zheng; 2006 Aug; 25(8):1007-12. PubMed ID: 16965684
[TBL] [Abstract][Full Text] [Related]
31. Performance at preoperative stair-climbing test is associated with prognosis after pulmonary resection in stage I non-small cell lung cancer.
Brunelli A; Pompili C; Berardi R; Mazzanti P; Onofri A; Salati M; Cascinu S; Sabbatini A
Ann Thorac Surg; 2012 Jun; 93(6):1796-800. PubMed ID: 22551844
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
Yang ZJ; Wei RJ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
[TBL] [Abstract][Full Text] [Related]
33. Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases.
Yan TD; Padang R; Morris DL
J Am Coll Surg; 2006 Jan; 202(1):100-11. PubMed ID: 16377503
[TBL] [Abstract][Full Text] [Related]
34. Prolongation of survival and improvement in performance status following palliative chemotherapy in gastrointestinal cancer patients with a poor performance status.
Shitara K; Munakata M; Kasai M; Muto O; Sakata Y
Oncology; 2008; 74(3-4):135-42. PubMed ID: 18714163
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
[TBL] [Abstract][Full Text] [Related]
36. Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial.
Paz-Ares L; de Marinis F; Dediu M; Thomas M; Pujol JL; Bidoli P; Molinier O; Sahoo TP; Laack E; Reck M; Corral J; Melemed S; John W; Chouaki N; Zimmermann AH; Visseren-Grul C; Gridelli C
Lancet Oncol; 2012 Mar; 13(3):247-55. PubMed ID: 22341744
[TBL] [Abstract][Full Text] [Related]
37. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
[TBL] [Abstract][Full Text] [Related]
38. Radiotherapy for stage III non-small-cell lung carcinoma in the elderly (age ≥ 70 years).
Aridgides PD; Janik A; Bogart JA; Duffy S; Rosenbaum P; Gajra A
Clin Lung Cancer; 2013 Nov; 14(6):674-9. PubMed ID: 23891240
[TBL] [Abstract][Full Text] [Related]
39. Bronchoscopic debulking for endobronchial malignancy: Predictors of recanalization and recurrence.
Kuo SC; Lo YL; Chou CL; Chung FT; Lin SM; Liu CY; Kuo HP
Thorac Cancer; 2015 Nov; 6(6):722-30. PubMed ID: 26557910
[TBL] [Abstract][Full Text] [Related]
40. How much evidence isn't in evidence-based guidelines?
Johnson MJ; Currow DC
Ann Oncol; 2016 Jan; 27(1):205. PubMed ID: 26489446
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
